Latest stories on DFTX
Definium Therapeutics Announces New Employee Inducement Grants
StockTitan50 · neutralgeneral
Definium Therapeutics Announces New Employee Inducement Grants
StockTitan50 · neutralgeneral
Definium Therapeutics: Outstanding Phase III Data De-Risks Pipeline, But Patience Required Ahead Of 2027
Seeking Alpha58 · neutralanalyst
Why is Definium Therapeutics stock gaining today?
Investing.com Markets61 · neutralgeneral
Definium Therapeutics initiated with an Overweight at JPMorgan
The Fly63 · neutralanalyst
Definium Therapeutics Announces New Employee Inducement Grants
StockTitan50 · neutralgeneral
Definium’s LSD Pill Clears a Second Anxiety Trial, and the Psychedelics Sector Is Watching
Yahoo Top73 · bullishproduct/pr
Definium Therapeutics Logs Third Positive Phase 3 Readout for DT120 in Anxiety
TipRanks73 · bullishproduct/pr
Definium Therapeutics Issues Inducement Stock Options to New Hires
TipRanks50 · neutralgeneral
Canaccord raises Definium Therapeutics price target on trial results
Investing.com Analyst Ratings61 · neutralanalyst
H.C. Wainwright reiterates Definium stock rating on positive trial data
Investing.com Analyst Ratings63 · neutralanalyst
Definium Therapeutics price target raised to $75 from $70 at Oppenheimer
The Fly63 · neutralanalyst
Definium Therapeutics price target raised to $91 from $75 at BofA
The Fly61 · neutralanalyst
DFTX Stock Climbs As High As 12% On ‘Unprecedented’ Anxiety Data For LSD-Based Drug
Stocktwits News67 · bullishproduct/pr
Definium rises as LSD pill achieves primary goal in late-stage trial for anxiety
Seeking Alpha73 · bullishproduct/pr
First Marijuana, Then Peptides. Why Psychedelics Are Wall Street’s Next Big Trip.
Barron's73 · bullishproduct/pr
Stifel raises Definium Therapeutics stock price target on trial win
Investing.com Analyst Ratings61 · neutralanalyst
Definium Therapeutics Shares Rise 20% After Phase 3 Anxiety Trial Meets Primary Endpoint
InvestorsHub73 · bullishproduct/pr
Definium, Up 190% This Year, Succeeds Again With Synthetic LSD; Shares Fly
Investors.com78 · bullishproduct/pr
Definium Therapeutics, Inc. (DFTX) files 8-K
SEC 8-K50 · neutralgeneral
Why is Definium Therapeutics stock surging today?
Investing.com Markets50 · neutralgeneral
S&P 500 Futures Decline in Premarket Trading; Definium Therapeutics, Primo Brands Lead
Barron's42 · neutralgeneral
Definium says Phase 3 Panorama study met primary, secondary efficacy endpoints
The Fly73 · bullishproduct/pr
Definium's LSD-based drug lowers anxiety in second successful late-stage study
Reuters67 · bullishproduct/pr